NAYA Biosciences ( (NAYA) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NAYA Biosciences, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for the delay is the additional time required to finalize its financial statements. The company anticipates filing the report within a 15-day extension period. NAYA Biosciences expects a significant financial impact, with revenue for 2024 projected to increase by approximately 117% compared to 2023, primarily due to the acquisition of Wisconsin Fertility Institute. The notification was signed by CEO Steve Shum, indicating ongoing compliance efforts.
More about NAYA Biosciences
YTD Price Performance: -79.42%
Average Trading Volume: 28,666
Technical Sentiment Signal: Buy
Current Market Cap: $1.33M
For a thorough assessment of NAYA stock, go to TipRanks’ Stock Analysis page.